Accro Bioscience to Unveil Phase II Data at European Dermatology Congress 2025 Accro Bioscience is set to present crucial Phase II clinical data on AC-201 for treating plaque psoriasis at EADV Congress 2025 in Paris. Discover the latest advancements.

Accro Bioscience to Unveil Phase II Data at European Dermatology Congress 2025 #None #Paris #Plaque_Psoriasis #AC-201 #Accro_Bioscience